| Entry |
|
| Name |
Mizolastine (JAN/INN);
Mizollen (TN)
|
| Formula |
C24H25FN6O
|
| Exact mass |
432.2074
|
| Mol weight |
432.4933
|
| Structure |

     |
| Activity |
antihistaminics
|
| Remark |
|
| Target |
|
| Pathway |
hsa04020 Calcium signaling pathway hsa04080 Neuroactive ligand-receptor interaction | |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX25 Mizolastine
D01117 Mizolastine (JAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
H1-receptor [HSA:3269] [KO:K04149]
Mizolastine
D01117 Mizolastine (JAN/INN)
 |
| Other DBs |
CAS: 108612-45-9 PubChem: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 32
1 C1b C 22.1907 -15.3549
2 C8y C 20.9802 -14.6492
3 C8x C 20.9897 -13.2479
4 C8x C 19.7791 -12.5420
5 C8y C 18.5626 -13.2375
6 C8x C 18.5567 -14.6388
7 C8x C 19.7673 -15.3445
8 X F 17.3521 -12.5316
9 N4y N 22.1800 -16.7509
10 C8x C 18.4164 -17.1795
11 C8x C 18.4164 -18.5808
12 C8x C 19.6329 -19.2814
13 C8x C 19.6329 -16.4788
14 C8y C 20.8423 -17.1795
15 C8y C 20.8365 -18.5842
16 N5x N 22.1707 -19.0239
17 C8y C 23.0008 -17.8908
18 N1y N 24.3966 -17.8873
19 C1x C 25.0978 -19.0944
20 C1x C 26.4936 -19.0909
21 C1y C 27.1885 -17.8801
22 C1x C 26.4875 -16.6731
23 C1x C 25.0915 -16.6767
24 N1c N 28.5898 -17.8766
25 C8y C 29.2935 -19.0883
26 C1a C 29.2874 -16.6613
27 N5x N 28.5925 -20.2955
28 C8x C 29.2962 -21.5072
29 C8x C 30.6975 -21.5036
30 C8y C 31.3951 -20.2882
31 N4x N 30.6914 -19.0764
32 O5x O 32.7964 -20.2846
BOND 36
1 11 12 2
2 12 15 1
3 14 13 1
4 14 15 2
5 15 16 1
6 17 18 1
7 1 9 1
8 2 3 2
9 3 4 1
10 4 5 2
11 5 6 1
12 18 19 1
13 19 20 1
14 20 21 1
15 21 22 1
16 22 23 1
17 23 18 1
18 6 7 2
19 21 24 1
20 7 2 1
21 24 25 1
22 1 2 1
23 24 26 1
24 5 8 1
25 16 17 2
26 17 9 1
27 9 14 1
28 13 10 2
29 25 27 2
30 27 28 1
31 28 29 2
32 29 30 1
33 30 31 1
34 31 25 1
35 10 11 1
36 30 32 2
|